Conduit Pharmaceuticals
Price & Volume
Stats
See moreOpen | $0.54 |
Previous Close | $0.55 |
Day Range | $0.53-$0.56 |
52W Range | $0.51-$350 |
Market Cap | $6.4M |
Shares Short | 1M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$20.53 |
News
See moreYahoo Finance • 16 days ago
Conduit Pharmaceuticals Announces Leadership Changes
Yahoo Finance • 21 days ago
Conduit Pharmaceuticals Announces Novel Cocrystal Patent Filing For VTAMA® (tapinarof) with Enhanced Therapeutic and Market Extension Prospects
Yahoo Finance • last month
Conduit Pharmaceuticals Receives U.S. Patent Approval For Its Lead Asset Targeting Autoimmune Diseases
Yahoo Finance • 2 months ago
Conduit Pharmaceuticals Provides Update on Nasdaq Stock Market Hearing Panel
About
CEO | Dr. Andrew Regan |
CFO | Mr. James Bligh |
Address | 4581 Tamiami Trail North, Naples, FL, United States, 34103 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 6 |
